English
Back
Download
Log in to access Online Inquiry
Back to the Top
avatar
Jaguar8 commented on a stock · Apr 26, 2024 20:07

$Cidara Therapeutics (CDTX.US)$ NEWS Cidara Therapeutics Ann...

NEWS
Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388 at ESCMID 2024

Cidara Therapeutics announced data presentations at ESCMID 2024 on CD388, highlighting Phase 1 and Phase 2a clinical data. The Phase 2a study showed CD388 was well-tolerated with significant antiviral effects in healthy volunteers challenged with influenza. The Phase 1 study demonstrated an extended half-life of 6-8 weeks, indicating potential for seasonal influenza prevention.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
Translate
Report
6610 Views
Comment
Sign in to post a comment
    avatar
    Jaguar8
    Spread kindness and love. Life is short. Don’t let greed eat you.
    9579
    Followers
    55
    Following
    116K
    Visitors
    Follow

    Market Insights

    Market Hot Picks Market Hot Picks
    No. Symbol Price
    Tesla
    TSLA
    268.460
    NVIDIA
    NVDA
    110.150
    Newsmax
    NMAX
    233.000
    4
    CoreWeave
    CRWV
    52.570
    5
    Palantir
    PLTR
    84.680
    Log In for the Full List
    Unlock Now

    Trump's comeback to the Office

    Following Trump's Policies to Seek Investment Opportunities

    Monetary Policy: Navigating the Fed's Rate Cut Cycle

    Changing Fed policy is altering the market math for investors.

    Reassessing Chinese Assets

    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

    - No more -